Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

EFTRENONACOG ALFA for Haemarthrosis: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 6 adverse event reports in the FDA FAERS database where EFTRENONACOG ALFA was used for Haemarthrosis.

Most Reported Side Effects for EFTRENONACOG ALFA

Side Effect Reports % Deaths Hosp.
Haemorrhage 802 37.5% 0 82
Haemarthrosis 196 9.2% 0 31
Fall 151 7.1% 0 36
Contusion 108 5.1% 0 15
Arthralgia 104 4.9% 0 13
Traumatic haemorrhage 93 4.4% 0 14
Limb injury 83 3.9% 0 8
Head injury 76 3.6% 0 24
Epistaxis 73 3.4% 0 11
Spontaneous haemorrhage 71 3.3% 0 6
Joint injury 63 3.0% 0 5
Joint swelling 62 2.9% 0 11
Pain 61 2.9% 0 13
Muscle haemorrhage 46 2.2% 0 3
Injury 45 2.1% 0 8

Other Indications for EFTRENONACOG ALFA

Factor ix deficiency (1,133) Haemophilia (148) Haemorrhage (109) Product used for unknown indication (93) Prophylaxis (77) Haemorrhage prophylaxis (34) Factor viii deficiency (17) Immune tolerance induction (16)

Other Drugs Used for Haemarthrosis

ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT (67) COAGULATION FACTOR IX RECOMBINANT HUMAN (26) COAGULATION FACTOR IX RECOMBINANT HUMAN\ISOPROPYL ALCOHOL (11) EFMOROCTOCOG ALFA (10) ANTI-INHIBITOR COAGULANT COMPLEX (9) COAGULATION FACTOR VIIA RECOMBINANT HUMAN (7) ANTIHEMOPHILIC FACTOR HUMAN (6) --BLOOD-COAGULATION FACTOR VIII FUSION PROTEIN WITH IMMUNOGLOBULIN G1 , ,-BIS WITH IMMUNOGLOBULIN G1 (6) ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT RESIDUES 743-1636 DELETED (5) DAMOCTOCOG ALFA PEGOL (5)

Related Pages

EFTRENONACOG ALFA Full Profile All Haemarthrosis Drugs EFTRENONACOG ALFA Demographics EFTRENONACOG ALFA Timeline